RGK GTPases/Ca2+ Channel Cross Talk
RGK GTPases/Ca2+ Channel Cross Talk
批准号:
7787440
负责人:
Henry M. Colecraft
金额:
$40.25万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-15 至 2012-03-31
关键词:
AddressAffectAffinityArrhythmiaAtrial FibrillationAutistic DisorderBindingBiologicalCalmodulinCardiacCardiovascular DiseasesCell membraneCellsCommunicationDataDetectionDimensionsDiseaseDissociationEnvironmentEventFamilyGene ExpressionGenerationsGuanosine Triphosphate PhosphohydrolasesHeartHeart DiseasesHeart failureHypertensionKineticsKnowledgeLifeLinkMediatingMembraneMethodsMolecular ProfilingMonitorMuscle ContractionNeurologicPhysiologicalPhysiologyPreparationProcessProtein FamilyProteinsRelative (related person)Research PersonnelResolutionSignal TransductionStrokeSynapsesTherapeuticchannel blockersexpectationheart cellinhibitor/antagonistinsightnew technologynovelpractical applicationprogramsprotein expressiontraffickingvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project focuses on a recently discovered crosstalk between two protein families: high-voltage-activated Ca2+ (CaV) channels and the Rem/Rad/Gem/Kir (RGK) family of Ras-like GTPases. Ca2+ influx through CaV channels (ICa) regulates many essential processes including muscle contraction, synaptic communication, and gene expression. Dysregulation of ICa is linked to diverse neurological and cardiovascular disorders including autism and cardiac arrhythmias. Conversely, blockade of ICa is an important therapy for serious diseases such as angina, stroke, and hypertension. RGK GTPases were recently revealed to potently inhibit CaV channels by interacting with auxiliary CaVbeta subunits. Because RGK proteins are widely prevalent, and their expression differentially regulated in disease, their crosstalk with CaV channels is well-placed to regulate many Ca2+-dependent biological and pathophysiological events. Moreover, RGK GTPases represent a new archetype of ICa inhibitors that could be potentially exploited to generate novel genetically-encoded CaV-channel blockers with therapeutic and practical applications. We seek to address critical unknowns related to the action of RGK GTPases on CaV channels that limit insights into the (patho)physiological impact of this crosstalk, and its latent beneficial exploitation. Our long-term objective is to gain an in-depth understanding of mechanisms underlying the RGK GTPase/CaV-channel crosstalk and apply this knowledge to: (1) an appreciation of how this interaction contributes to (patho)physiology, and (2) create a new generation of useful genetically-encoded CaV- channel inhibitors. We propose 3 Aims: (1) Clarify the impact of RGK proteins on the gating and trafficking of CaV channels and elucidate the underlying mechanisms. (2) Characterize the functional impact of Ca2+- CaM on the RGK GTPase/CaV channel crosstalk. (3) Determine the expression profile of RGK GTPases in heart and define the functional impact of their crosstalk with L-type CaV channels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
-
批准号:10628914
-
项目类别:
-
资助金额:$48.43万
-
财政年份:2023
-
负责人:Henry M. Colecraft
-
依托单位:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
-
批准号:10628911
-
项目类别:
-
资助金额:$241.3万
-
财政年份:2023
-
负责人:Henry M. Colecraft
-
依托单位:
Novel genetically-encoded inhibitors to probe functional logic of Cav-beta molecular diversity
-
批准号:10581282
-
项目类别:
-
资助金额:$44.98万
-
财政年份:2022
-
负责人:Henry M. Colecraft
-
依托单位:
Towards Novel Therapies for CACNA1A Neurological Disorders
-
批准号:10589799
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2022
-
负责人:Henry M. Colecraft
-
依托单位:
Nanobodies for Probing CACNA2D2 and CACNA2D3 Function, Expression, and Therapeutics
-
批准号:10217683
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2021
-
负责人:Henry M. Colecraft
-
依托单位:
FASEB SRC on Ion Channel Regulation
-
批准号:9756745
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2019
-
负责人:Henry M. Colecraft
-
依托单位:
Ubiquitin Regulation of K Channels in Health and Disease
-
批准号:10470075
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2018
-
负责人:Henry M. Colecraft
-
依托单位:
Mechanisms of Long QT Syndrome 1 in Heart
-
批准号:9038483
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2016
-
负责人:Henry M. Colecraft
-
依托单位:
L-type calcium channel trafficking and modulation in heart
-
批准号:9266817
-
项目类别:
-
资助金额:$57.85万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
Small G-protein Regulation of Calcium Channels
-
批准号:8695923
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
L-type calcium channel trafficking and modulation in heart
-
批准号:8896044
-
项目类别:
-
资助金额:$56.95万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
L-type calcium channel trafficking and modulation in heart
-
批准号:8759443
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
Small G-protein Regulation of Calcium Channels
-
批准号:9036274
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
L-type channel trafficking and modulation in heart
-
批准号:10750659
-
项目类别:
-
资助金额:$81.47万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
Small G-protein Regulation of Calcium Channels
-
批准号:9247954
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
Small G-protein Regulation of Calcium Channels
-
批准号:8827383
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
L-type calcium channel trafficking and modulation in heart
-
批准号:9054912
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
L-type channel trafficking and modulation in heart
-
批准号:9920759
-
项目类别:
-
资助金额:$71.49万
-
财政年份:2014
-
负责人:Henry M. Colecraft
-
依托单位:
Chemical tools for profiling and visualizing functioning ion channel complexes
-
批准号:7819759
-
项目类别:
-
资助金额:$49.93万
-
财政年份:2009
-
负责人:Henry M. Colecraft
-
依托单位:
Chemical tools for profiling and visualizing functioning ion channel complexes
-
批准号:7933882
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2009
-
负责人:Henry M. Colecraft
-
依托单位:
海外基金